Fidelis Diagnostics Partners with Nationwide Medical to Add Turnkey Sleep Disorder Solutions to Its Growing Portfolio of Services

Fidelis Diagnostics, Inc., a rapidly growing healthcare company providing innovative diagnostic services nationally, today announced it has entered into a strategic partnership with Nationwide Medical, Inc.,  a company dedicated to the service and aftercare of patients with Obstructive Sleep Apnea (OSA). Together, Fidelis Diagnostics and Nationwide Medical will offer turnkey solutions for physicians and their patients that encompass the initial diagnosis of OSA, as well as the ongoing medical management of the disease.

“Our strategic relationship with Nationwide Medical makes the initial diagnosis of OSA easier and more convenient for physicians and their patients, and it also bridges the gap between the initial diagnosis of OSA and its clinical treatment and aftercare,” said Amir London, COO of Fidelis Diagnostics. Fidelis Diagnostics Partners with Nationwide Medical “By working with a dedicated provider like Nationwide Medical, we now provide a continuum of care to ensure the health and well-being of patients suffering from sleep disorders through proper diagnosis followed by consistent on-going treatment to optimize their therapy.”  

Fidelis Diagnostics offers a more convenient way to diagnose sleep apnea with Home Sleep Studies using WatchPAT, an innovative, clinically proven, FDA-approved in home sleep study device providing accurate detection of sleep apnea. Used in the comfort of the patient’s own bedroom (an environment that best reflects the usual sleep habits), it provides more reliable and precise results than those obtained in traditional sleep labs.

“We are excited about our relationship with Fidelis Diagnostics, which brings together the best in innovative diagnostic testing, and includes Nationwide Medical’s dedicated service and aftercare programs for the millions of patients living with OSA,” said Sean Martin, VP of Sales and Business Development for Nationwide Medical.  “All too often, CPAP patients don’t know who to turn to when they have equipment concerns or needs, causing unnecessary frustration and unfortunate failed therapy. Once patients are diagnosed, it is critical to educate and provide comprehensive and dedicated on-going care to optimize successful therapy. That type of ongoing service is the benchmark of Nationwide Medical, Inc.’s core philosophy”


It is estimated that Obstructive Sleep Apnea (OSA) affects nearly 23 million working Americans and can have hazardous effects on health and quality of life - ranging from high blood pressure and other cardiovascular disorders to cognitive weakening, headaches, degradation of social and work-related activities, and increased risk of car and work-related accidents. Now those likely to suffer from sleep disorders can be more conveniently tested and then followed with a course of treatment. 

About Nationwide Medical, Inc-

Nationwide Medical, Inc. (NMI) is a company dedicated to the service and aftercare of patients with Obstructive Sleep Apnea.  It currently provides CPAP equipment and clinical care to 24,000 active patients.  All NMI patients receive follow up contact at least every 90 days for the lifetime of their treatment.  NMI believes that it is imperative to stay in constant contact with its patients to ensure the best possibility of treatment compliance.  A team of certified respiratory therapists, along with sleep coaches and service personnel provide turn-key solutions to physicians diagnosing and treating OSA.  For more information, visit the Website at www.nationwidemedical.com.

About Fidelis Diagnostics, Inc.

Headquartered in Los Angeles, Fidelis Diagnostics is a rapidly growing healthcare company providing a portfolio of innovative diagnostic services to physicians nationwide. Since its inception in 2004, the company has built an exceptional reputation for its quality diagnostics, high standard of business ethics and outstanding service, improving patient health with convenient testing, while reducing overall healthcare costs. In addition to Home Sleep Studies utilizing the innovative FDA-approved WatchPAT device, Fidelis services include ElectroDiagnostics, Audiology Testing, ABI technology and H.pylori Breath Testing Solution being provided to thousands of physicians across the United States.

Media contacts:

Agnes Huff, PhD

Agnes Huff Communications

310.641.2525 or ahuff@ahuffgroup.com

Sean Martin

Nationwide Medical, Inc.

818.338.3744 or smartin@nationwidemedical.com